Interactive debate: should there be greater emphasis on combination therapy, particularly fixed-dose combinations, in the treatment guidelines?
Topic:
Treatment of hypertension
Speaker:
Doctor A. De La Sierra (Terrassa, ES)
Professor B. Williams (London, GB)
Professor M. Burnier (Lausanne, CH)
Professor M. Volpe (Rome, IT)
Sponsored by Menarini group and Daiichi Sankyo Co., Ltd
Event:
ESC Congress 2017
Congress Presentation
About the speakers
Doctor Alejandro De La Sierra
UNIVERSITY HOSPITAL MUTUA DE TERRASSA, Terrassa (Spain)
5
presentations
0
follower
Professor Bryan Williams
University College London, London (United Kingdom of Great Britain & Northern Ireland)
70
presentations
6
followers
Professor Michel Burnier
University of Lausanne, Lausanne (Switzerland)
16
presentations
0
follower
Professor Massimo Volpe
Sapienza University of Rome, Rome (Italy)
12
presentations
1
follower
5 more presentations in this session
Welcome and introduction: renin-angiotensin system blockade as the basis for combination therapy.
Speaker: Professor M. Burnier (Lausanne, CH)
Angiotensin receptor blocker-based single-pill platform: a practical approach.
Speaker: Professor M. Volpe (Rome, IT)
Combination therapies and BP control: the spanish hypertension registry experience.
Speaker: Doctor A. De La Sierra (Terrassa, ES)
Summary and meeting close - Achieving better blood pressure control with fixed-dose combination therapy.
Speaker: Doctor A. De La Sierra (Terrassa, ES)
Access the full session
Achieving better blood pressure (BP) control with fixed-dose combination (FDC) therapy
Speakers:
Doctor A. De La Sierra, Professor B. Williams, Professor M. Burnier, Professor M. Volpe, Professor M. Burnier...
About the event
ESC 365 is supported by
